BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horowitz NB, Mohammad I, Moreno-Nieves UY, Koliesnik I, Tran Q, Sunwoo JB. Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies. Front Immunol 2021;12:648580. [PMID: 33968039 DOI: 10.3389/fimmu.2021.648580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Piro G, Carbone C, Agostini A, Esposito A, De Pizzol M, Novelli R, Allegretti M, Aramini A, Caggiano A, Granitto A, De Sanctis F, Ugel S, Corbo V, Martini M, Lawlor RT, Scarpa A, Tortora G. CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer. Br J Cancer 2022. [DOI: 10.1038/s41416-022-02028-6] [Reference Citation Analysis]
2 Chiu W, Ou D, Tan C. Mouse Models for Immune Checkpoint Blockade Therapeutic Research in Oral Cancer. IJMS 2022;23:9195. [DOI: 10.3390/ijms23169195] [Reference Citation Analysis]
3 Bruss C, Kellner K, Ortmann O, Seitz S, Brockhoff G, Hutchinson JA, Wege AK. Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice. Cancers (Basel) 2022;14:2214. [PMID: 35565343 DOI: 10.3390/cancers14092214] [Reference Citation Analysis]
4 Aramini B, Masciale V, Grisendi G, Bertolini F, Maur M, Guaitoli G, Chrystel I, Morandi U, Stella F, Dominici M, Haider KH. Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers (Basel) 2022;14:976. [PMID: 35205721 DOI: 10.3390/cancers14040976] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]